FY24 consensus $2.21. Backs FY24 revenue view $58.5B-$61.5B, consensus $60.02B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Genmab-Pfizer gain full FDA approval for TIVDAK in Metastatic Cervical Cancer
- Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay
- Options Volatility and Implied Earnings Moves This Week, April 29 – May 02, 2024
- PFE Upcoming Earnings Report: What to Expect?
- Pfizer (NYSE:PFE) Notches Up on New FDA Approval